Sinopharm Group Co., Ltd. (SHTDF)
Sinopharm Group Market Cap: 7.880B for Dec. 8, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sinovac Biotech Ltd. | 464.94M |
| China Pharma Holdings, Inc. | 5.839M |
| CASI Pharmaceuticals, Inc. | 17.55M |
| Zai Lab Ltd. | 2.070B |
| Adagene, Inc. | 89.98M |
Market Cap Related Metrics
| PE Ratio | 8.347 |
| PS Ratio | 0.0987 |
| Price to Free Cash Flow | 31.35 |
| Price | 2.525 |
| Earnings Yield | 11.98% |
| Operating PE Ratio | 3.44 |
| Normalized PE Ratio | 7.533 |